{
     "PMID": "8742040",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19960926",
     "LR": "20151119",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "203",
     "IP": "1",
     "DP": "1996 Jan 12",
     "TI": "Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta.",
     "PG": "33-6",
     "AB": "Exposure of rat hippocampal neurons to the peptide amyloid beta (A beta) (25-35) as well as A beta (1-40) peptides enhances phosphorylation of tau to a paired helical filament (PHF)-state through activation of tau protein kinase I (TPK I)/glycogen synthase kinase-3 beta (GSK-3 beta) [Busciglio, J., Lorenzo, A., Yeh, J. and Yankner, B.A., Neuron, 14 (1995) 879-888; Takashima, A., Ishiguro, K., Noguchi, K., Michel, G., Hoshi, M., Sato, K., Takahashi, M., Hoshino, T., Uchida, T. and Imahori, K., Neurosci. Meeting Abstr., 671 (1995) 17]. In order to examine the effects of A beta treatment on intracellular signaling mechanism, we have investigated the role of phosphatidyl inositol-3 (PI-3) kinase in the phosphorylation of tau. A beta (25-35) exposure induced an inactivation of PI-3 kinase and an activation of TPK I/GSK-3 beta in rat hippocampal culture. Wortmannin, an inhibitor of PI-3 kinase, also activated TPK I/GSK-3 beta, leading to an enhancement of tau phosphorylation and neuronal death in hippocampal culture. These results suggest that A beta (25-35) inhibition of PI-3 kinase results in the activation of TPK I/GSK-3 beta, the phosphorylation of tau, and resultant neuronal death in rat hippocampal neurons.",
     "FAU": [
          "Takashima, A",
          "Noguchi, K",
          "Michel, G",
          "Mercken, M",
          "Hoshi, M",
          "Ishiguro, K",
          "Imahori, K"
     ],
     "AU": [
          "Takashima A",
          "Noguchi K",
          "Michel G",
          "Mercken M",
          "Hoshi M",
          "Ishiguro K",
          "Imahori K"
     ],
     "AD": "Mitubishi Kasei Institute of Life Sciences, Tokyo, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Amyloid beta-Protein Precursor)",
          "0 (Androstadienes)",
          "0 (Enzyme Inhibitors)",
          "0 (tau Proteins)",
          "EC 2.4.1.11 (Glycogen Synthase)",
          "EC 2.7.- (Phosphotransferases)",
          "XVA4O219QW (wortmannin)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/metabolism",
          "Amyloid beta-Protein Precursor/*pharmacology",
          "Androstadienes/pharmacology",
          "Animals",
          "Cells, Cultured/drug effects",
          "Dose-Response Relationship, Drug",
          "Enzyme Inhibitors/pharmacology",
          "Glycogen Synthase/*drug effects",
          "Hippocampus/*drug effects",
          "Phosphotransferases/*drug effects",
          "Rats",
          "tau Proteins/*drug effects"
     ],
     "EDAT": "1996/01/12 00:00",
     "MHDA": "1996/01/12 00:01",
     "CRDT": [
          "1996/01/12 00:00"
     ],
     "PHST": [
          "1996/01/12 00:00 [pubmed]",
          "1996/01/12 00:01 [medline]",
          "1996/01/12 00:00 [entrez]"
     ],
     "AID": [
          "0304394095122575 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 1996 Jan 12;203(1):33-6.",
     "term": "hippocampus"
}